Adrenal function as assessed by low-dose adrenocorticotropin hormone test before and after switching from inhaled beclomethasone dipropionate to inhaled fluticasone propionate

Journal of Asthma

Volumn 40, Issue 5, 2003, Pages 515-522

  Niitsuma, Tomoyuki ^a   Okita, Misa ^a   Sakurai, Kahori ^a   Morita, Sonoko ^a   Tsuyuguchi, Miyako ^a   Matsumura, Yasuhiro ^a   Hayashi, Tohru ^a   Koshishi, Tohru ^b   Oka, Kitaro ^b   Homma, Masato ^c  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Beclomethasone dipropionate; Fluticasone propionate; Low dose ACTH test

Indexed keywords

BECLOMETASONE DIPROPIONATE; CORTICOTROPIN; FLUTICASONE PROPIONATE; HYDROCORTISONE; TETRACOSACTIDE;

ADRENAL DISEASE; ADRENAL FUNCTION; ADULT; AGED; ARTICLE; ASTHMA; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CORTICOTROPIN BLOOD LEVEL; CORTICOTROPIN TEST; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; LUNG FUNCTION; MALE; PEAK EXPIRATORY FLOW;

ADMINISTRATION, INHALATION; ADRENAL INSUFFICIENCY; ADRENOCORTICOTROPIC HORMONE; ADULT; AGED; ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; BECLOMETHASONE; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; PEAK EXPIRATORY FLOW RATE; PITUITARY-ADRENAL FUNCTION TESTS;

EID: 0141508884     PISSN: 02770903     EISSN: None     Source Type: Journal    
DOI: 10.1081/JAS-120018781     Document Type: Article

References (27)

1. National Heart, Lung, and Blood Institute. NHLBI/WHO Workshop Global Strategy for Asthma Management and Prevention Report. Publication No. 95-3659, Global Initiative for Asthma. Bethesda, MD: National Heart, Lung, and Blood Institute, 1995.
2. Gaddie J, Petrie GR, Reid IW, Sinclair DJM, Skinner C, Palmer KNV. Aerosol beclomethasone dipropionate: a dose-response study in chronic bronchial asthma. Lancet ii 1973; 280-281.
3. Smith MJ, Hodson ME. Effects of long term inhaled high dose beclomethasone dipropionate on adrenal function. Thorax 1983; 38:676-681.
4. Broide J, Soferman R, Kivity S, Golander A, Dickstein G, Spirer Z, Weisman Y. Low-dose adrenocorticotropin test reveals impaired adrenal function in patients taking inhaled corticosteroids. J Clin Endocrinol Metab 1995; 80:1243-1246.
5. Dickstein G, Shechner C, Nicholson WE, Rosner I, Shen-orr Z, Adawi F, Lahav M. Adrenocorticotropin stimulation test: effects of basal cortisol level, time of day, and suggested new sensitive low dose test. J Clin Endocrinol Metab 1991; 72:773-778.
6. Crowley S, Hindmarsh PC, Holownia P, Honour JW, Brook CGD. The use of low doses of ACTH in the investigation of adrenal function in man. J Endocrinol 1991; 130:475-479.
7. Crowley S, Hindmarsh PC, Holownia P, Honour JW, Brook CGD. Reproducibility of the cortisol response to stimulation with a low dose of ACTH (1-24): The effect of basal cortisol levels and comparison of low-dose with high-dose secretory dynamics. J Endocrinol 1993; 136:67-172.
8. Daidoh H, Morita H, Mune T, Murayama M, Hanafusa J, Ni H, Shibata H, Yasuda K. Responses of plasma adrenocortical steroids to low dose ACTH in normal subjects. Clin Endocrinol 1995; 43:311-315.
9. Tordjman K, Jaffe A, Grazas N, Apter C, Stern N. The role of the low dose (1 μg) adrenocorticotropin test in the evaluation of patients with pituitary diseases. J Clin Endocrinol Metab. 1995; 80:1301-1305.
10. Rasmuson S, Olsson T, Hagg E. A low dose ACTH test to assess the function of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol 1996; 44:151-156.
11. Oka K, Ohki N, Noguchi M, Matsuoka Y, Irimajiri S, Abe M, Takizawa T. Extraction-monitoring and rapid flow fractionation for determination of serum corticosteroids. Anal Chem 1984; 56:2614-2617.
12. Oka K, Noguchi M, Kitamura T, Shima S. Liquid chromatography and radioimmunoassay compared for determination of cortisol and corticosterone in plasma after a dexamethasone suppression test. Clin Chem 1987; 33:1639-1642.
13. Phillipps GH. Structure-activity relationships of topically active steroids: the selection of fluticasone propionate. Respir Med 1990; 84(suppl A):19-23.
14. Lundback B, Alexander M, Day J, Hebert J, Holzer R, Uffelen RV, Kesten S, Jonens AL. Evalution of fluticasone propionate (500 μg day-1) administered either as dry powder via a Diskhaler inhaler or pressurized inhaler and compared with beclomethasone dipropionate (1000 μg day-1) administered by pressurized inhaler. Respir Med 1993; 87:609-620.
15. Leblanc P, Mink S, Keistinen T, Saarelainen PA, Ringdal N, Payne SL. A comparison of fluticasone propionate 200 μg/day with beclomethasone dipropionate 400 μg/day in adult asthma. Allergy 1994; 49:380-385.
16. Bootsma GP, Dekhuijzen PN, Festen J, Mulder PG, van Herwaarden CL. Comparison of fluticasone propionate and beclomethasone dipropionate on direct and indirect measurements of bronchial hyperresponsiveness in patients with stable asthma. Thorax 1995; 50:1044-1050.
17. Pauwels RA, Yernault JC, Demedts MG, Geusens P. Safety and efficacy of fluticasone and beclomethasone in moderate to severe asthma. Am J Respir Crit Care Med 1998; 157:827-832.
18. Barnes NC, Hallett C, Harris TAJ. Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less. Respir Med 1998; 92:95-104.
19. Fitzgerald D, van Asperen P, Mellis C, Honner M, Smith L, Ambler G. Fluticasone propionate 750 μg/day versus beclomethasone dipropionate 1500 μg/day: comparison of efficacy and adrenal function in pediatric asthma. Thorax 1998; 53:656-661.
20. Newman SP, Woodman G, Clarke SW, Sackner MA. Effect of InspirEase on the deposition of metered-dose aerosols in the human respiratory tract. Chest 1986; 89:551-556.
21. Melchor R, Biddiscombe MF, Mak VHF, Short MD, Spiro SG. Lung deposition patterns of directly labelled salbutamol in normal subjects and in patients with reversible airflow obstruction. Thorax 1993; 48:506-511.
22. Hindle M, Newton DAG, Chrystyn H. Dry powder inhalers are bioequivalent to metered-dose inhalers. Chest 1995; 107:629-633.
23. Jonson M. Pharmacodynamics and pharmacokinetics of inhaled glucocorticoids. J Allergy Clin Immunol 1996; 97:169-176.
24. Falcoz C, Mackie AE, McDowall J, McRae J, Yogendran L, Ventresca GP, Bye A. Oral bioavailability of fluticasone propionate in healthy subjects. Br J Clin Pharmacol 1996; 41:459-460.
25. Brindly C, Falcoz C, Mackie AE, Bye A. Absorption kinetics after inhalation of fluticasone propionate via the diskhaler, discus and metered-dose inhaler in healthy volunteers. Clin Pharmacokinet 2000; 39(suppl 1):1-8.
26. Wilson AM, Dempsey OJ, Coutie WJR, Sims E, Lipworth BJ. Importance of drug-device interaction in determining systemic effects of inhaled corticosterids. Lancet 1999; 353:2128.
27. Eid N, Morton R, Olds B, Clark P, Sheikh S, Looney S. Decreased morning cortisol levels in children with asthma treated with inhaled fluticasone propionate. Pediatrics 2002; 109:217-221.